You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

EXPLORE THE COMPASS GROUP

Compass Associates

Multi-award-winning recruitment consultancy dedicated to the independent Health, Social Care and Children's Services sectors.

Compass Executives

Dedicated Executive Search services for Health, Social Care, Children's Services & Education and Life Sciences. Covering the UK, International Investor, Advisory Services and Private Business sectors.

Compass Corporate Services

Recruitment solutions with full coverage of HR, Finance & Accounting, Marketing & Communications and Property & Estates for the independent Health and Social Care markets.

Can the COVID-19 pandemic reconcile Big Pharma and Joe Public?

The COVID-19 pandemic has thrust us into an unfamiliar world with which the pharmaceutical industry has taken centre stage. We are witness to a vaccines arms race the likes of...

News

European Commission approves pharma trio’s Ranivisio

Therapy is a biosimilar of Lucentis which treats several serious retinal diseases across the European Union

The European Commission (EC) has granted marketing authorisation to Polpharma Biologics, Formycon and Bioeq jointly developed treatment Ranivisio – also known as ranibizumab – a biosimilar of Lucentis. The original therapy is already a treatment for several serious retinal diseases across the EU.